Summit Therapeutics Inc. (NASDAQ:SMMT) ranks as the best performing stock in 2024. The company focuses on developing innovative oncology treatments, with successful Phase 3 trials and collaborations. Despite stable R&D expenses, financial outlook improved through repurchasing notes and raising capital.